2024-11-08T08:20:35-06:00 2023-12-31 346565596 ERNST & YOUNG US LLP 221 E 4TH STSUITE 2900 CINNCINATI OH 45202 990 2023-01-01 822499905 GLOBAL GENOMICS AND BIOINFORMATICS RESEARCH INSTITUTE GLOB 5714728123 8095 INNOVATION PARK DRIVE FAIRFAX VA 22031 RICARDO TALENTO ACTING CFO 5714728123 2024-11-07 1 0 JULIE L SPARKS P01268401 5136121400 2023 2024-10-15 13:58:12Z J STEPHEN JONES MD 8095 INNOVATION PARK DRIVE FAIRFAX VA 22031 322656 0 X X 2016 VA THE RESEARCH INSTITUTE'S PRIMARY PURPOSE AND ACTIVITY IS SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST. X 2 2 0 4 0 0 198282 0 0 0 90255 322656 0 0 288537 322656 0 0 0 0 0 0 0 0 0 4862079 57094 4862079 57094 -4573542 265562 118445508 66703 42933010 0 75512498 66703 X THE RESEARCH INSTITUTE IS A VISIONARY INITIATIVE WITH A STATED MISSION OF IMPROVING THE HEALTH AND QUALITY OF LIFE OF DIVERSE COMMUNITIES THROUGH THE APPLICATION OF GENOMICS AND ASSOCIATED MOLECULAR SCIENCE TO DRIVE COMPUTATION ASSISTED INTELLIGENT INDIVIDUALIZED WELLNESS, DISCOVER ORIGINS OF DISEASE AND DEVELOP NOVEL INTERVENTIONS TO RESTORE HEALTH WHEN DISEASE OCCURS. 0 1 57094 0 THE RESEARCH INSTITUTE IS A VIRGINIA NONPROFIT, NONSTOCK CORPORATION ORGANIZED FOR MEDICAL RESEARCH AND SCIENTIFIC PURPOSES WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE "CODE"). THE RESEARCH INSTITUTE WAS A VISIONARY INITIATIVE OF ITS PRINCIPAL MEMBERS; INOVA HEALTH SYSTEM FOUNDATION, UNIVERSITY OF VIRGINIA, AND GEORGE MASON UNIVERSITY, ALL PROMINENT TAX-EXEMPT ORGANIZATIONS, ALL OF WHICH ARE ORGANIZATIONS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND/OR STATE INSTRUMENTALITIES.INOVA HEALTH CARE SERVICES ("IHCS"), A VIRGINIA NON-STOCK CORPORATION WHOLLY CONTROLLED BY INOVA, IS THE OWNER OF THE FORMER EXXONMOBIL CAMPUS IN FALLS CHURCH, VIRGINIA, (THE "ICPH CAMPUS"). IN THE CONTRIBUTION AND COLLABORATION AGREEMENT (THE "CCA") ENTERED INTO AS OF SEPTEMBER 14, 2018 AMONG THE PARTIES, THE PARTIES AGREED TO TAKE CERTAIN ACTIONS IN FURTHERANCE OF RETROFITTING "BUILDING C" ITS ADJOINING "BUILDING TOWERS AND CERTAIN OTHER "CAMPUS" IMPROVEMENTS (COLLECTIVELY, "BUILDING C") ON THE ICPH CAMPUS, WHICH WAS PREVIOUSLY COMMERCIAL OFFICE SPACE, FOR RESEARCH LABORATORIES, TOGETHER WITH SPACE IN OR ADJACENT TO BUILDING C FOR A VIVARIUM AND BIOREPOSITORY FOR THE INSTITUTE.THE PARTIES ANTICIPATED THAT THE RESEARCH INSTITUTE WOULD ENGAGE IN GENOMICS, BIOINFORMATICS AND OTHER RESEARCH ACTIVITIES CONSISTENT WITH ITS ARTICLES OF INCORPORATION, ITS BYLAWS ADOPTED IN ACCORDANCE WITH ITS ARTICLES OF INCORPORATION, APPLICABLE LAWS, AND THE RESEARCH INSTITUTE LEGISLATION.DUE TO VARIOUS INTERVENING CIRCUMSTANCES, THE PARTIES HAVE CONCLUDED THAT EACH CAN BETTER ADVANCE ITS RESPECTIVE MISSION BY MODIFYING THE SCOPE OF THE RETROFITTING OF BUILDING C, BY DISCONTINUING THE INSTITUTE, AND IN THE CASE OF UVA AND INOVA BY COLLABORATING DIRECTLY TO FURTHER THEIR RESPECTIVE MISSIONS AT THE ICPH CAMPUS. 57094 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 2 2 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 0 0 0 0 0 VA X GLOBAL GENOMICS AND BIOINFORMATICS RESEARCH INSTITUTE 5714728123 8095 INNOVATION PARK DRIVE FAIRFAX VA 22031 X DR K CRAIG KENT PRESIDENT 1.00 0.00 X X 0 0 0 DRSTEVE JMOTEW DIRECTOR 1.00 0.00 X 0 0 0 JOHN GAUL SECRETARY 1.00 0.00 X 0 0 0 DOUG LISCHKE TREASURER 1.00 0.00 X 0 0 0 0 0 0 0 0 0 0 0 322656 322656 322656 0 0 322656 X 57094 57094 57094 57094 0 0 41548085 66703 76897423 0 118445508 66703 42933010 0 42933010 0 X 75512498 66703 75512498 66703 118445508 66703 X 265562 -75711357 X 0 0 0 X 2859384 411359 3961281 198282 0 7430306 2859384 411359 3961281 198282 7430306 7430306 7613 2268 143 90255 322656 422935 7853241 X BUILDINGS AND IMPROVEMENTS ON ICPH CAMPUS 2023-03-31 76165588 COST OF CONSTRUCTION 540620889 INOVA HEALTH CARE SERVICES 8095 INNOVATION PARK DRIVE FAIRFAX VA 22031 501 (C)(3) 0 0 0 0 FORM 990, PART III, LINE 3 DUE TO VARIOUS INTERVENING CIRCUMSTANCES, THE RESEARCH INSTITUE HAS CONCLUDED THAT EACH MEMBER CAN BETTER ADVANCE ITS RESPECTIVE MISSION BY DISCONTINUING THE RESEARCH INSTITUTE, AND IN THE CASE OF UVA AND INOVA BY COLLABORATING DIRECTLY TO FURTHER THEIR RESPECTIVE MISSIONS AT THE ICPH CAMPUS. FORM 990, PART VI, SECTION A, LINE 6 THE RESEARCH INSTITUTE IS A VIRGINIA NONPROFIT, NONSTOCK CORPORATION ORGANIZED FOR MEDICAL RESEARCH AND SCIENTIFIC PURPOSES WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE "CODE"). THE MEMBERS OF THE RESEARCH INSTITUTE, INOVA HEALTH SYSTEM FOUNDATION, UNIVERSITY OF VIRGINIA AND GEORGE MASON UNIVERSITY, ARE ALL PROMINENT TAX-EXEMPT ORGANIZATIONS ALL OF WHICH ARE ORGANIZATIONS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND/OR STATE INSTRUMENTALITIES. FORM 990, PART VI, SECTION A, LINE 7A AS DESCRIBED IN THE BYLAWS, THE GOVERNING BODY OF THE ORGANIZATION IS THE BOARD OF DIRECTORS. THE BOARD IS COMPRISED OF UP TO TWO DIRECTORS. THE DIRECTORS ARE DESIGNATED AND APPOINTED BY EACH OF THE MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED AND PROVIDED TO THE CORPORATE CONTROLLER AND EXTERNAL TAX CONSULTANTS FOR INITIAL REVIEW. AFTER THE REVIEW IT IS GIVEN TO THE CFO OF INOVA HEALTH SYSTEM FOR REVIEW AND COMMENT. THE FORM 990 IS PRESENTED TO THE EXECUTIVE COMMITTEE OF THE BOARD OF TRUSTEES FOR ITS REVIEW. UPON COMPLETION OF THE EXECUTIVE COMMITTEE REVIEW, IT IS PROVIDED TO THE FULL BOARD OF TRUSTEES. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY THE ORGANIZATION DISTRIBUTES THE CONFLICT OF INTEREST POLICY TO ALL DIRECTORS, OFFICERS, TRUSTEES, AND KEY EMPLOYEES. THE PURPOSE OF THIS CONFLICT OF INTEREST POLICY ("POLICY") IS TO PROTECT THE INTEREST OF GLOBAL GENOMICS AND BIOINFORMATICS RESEARCH INSTITUTE (THE " RESEARCH INSTITUTE"), A VIRGINIA NONSTOCK CORPORATION, WHEN IT IS CONTEMPLATING ENTERING INTO A CONTRACT, TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF AN OFFICER OR DIRECTOR OF THE INSTITUTE OR OTHER INTERESTED PERSON (DEFINED BELOW). THE PRIMARY BENEFIT OF THE POLICY IS THAT THE BOARD OF DIRECTORS AND BOARD COMMITTEES CAN MAKE DECISIONS IN AN OBJECTIVE MANNER WITHOUT UNDUE INFLUENCE BY INTERESTED PERSONS. THIS POLICY CAN HELP TO ASSURE THAT THE INSTITUTE FULFILLS ITS NONPROFIT PURPOSES, PROPERLY OVERSEES THE ACTIVITIES OF ITS OFFICERS AND DIRECTORS, AND PAYS NO MORE THAN REASONABLE COMPENSATION TO HIGHLY COMPENSATED INDIVIDUALS. THE INSTITUTE ENCOURAGES INDIVIDUALS TO AVOID CONFLICTS OF INTEREST IN APPEARANCE AND IN FACT. THIS POLICY IS INTENDED TO SUPPLEMENT, BUT NOT REPLACE, ANY APPLICABLE STATE LAWS GOVERNING CONFLICTS OF INTEREST APPLICABLE TO NOT-FOR-PROFIT CORPORATIONS. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE NOT CURRENTLY PUBLICLY AVAILABLE. WHILE THE CONFLICT OF INTEREST POLICY IS NOT SPECIFICALLY PUBLICLY DISCLOSED, THE POLICY IS AVAILABLE TO MEMBERS. FORM 990, PART IX, LINE 11G OTHER PURCHASED SERVICES: PROGRAM SERVICE EXPENSES 57,094. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 57,094. FORM 990, PART XI, LINE 9: CIP WRITEOFF -75,711,357.